3 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 17 points (0.1%) at 13,052 as of Thursday, Dec. 6, 2012, 11:50 AM ET. The NYSE advances/declines ratio sits at 1,459 issues advancing vs. 1,413 declining with 145 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Baxter International ( BAX), up 0.6%. Top gainers within the industry include Bio-Reference Labs ( BRLI), up 5.4%, ResMed ( RMD), up 1.2%, Mindray Medical International ( MR), up 1.2%, Universal Health Services ( UHS), up 1.2% and Edwards Life ( EW), up 0.9%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry lower today:

3. DENTSPLY International ( XRAY) is one of the companies pushing the Health Services industry lower today. As of noon trading, DENTSPLY International is down $0.25 (-0.6%) to $39.03 on light volume Thus far, 232,157 shares of DENTSPLY International exchanged hands as compared to its average daily volume of 835,500 shares. The stock has ranged in price between $38.85-$39.19 after having opened the day at $39.05 as compared to the previous trading day's close of $39.28.

DENTSPLY International Inc. designs, develops, manufactures, and markets dental consumable products, dental laboratory products, and dental specialty products worldwide. DENTSPLY International has a market cap of $5.6 billion and is part of the health care sector. The company has a P/E ratio of 24.8, above the S&P 500 P/E ratio of 17.7. Shares are up 11.9% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate DENTSPLY International a buy, 2 analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DENTSPLY International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full DENTSPLY International Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

Bullish and Bearish Reversals in the Market

As Trump and Trudeau Tout Women's Council, Here's Who Is and Isn't Doing a Good Job at Diversity

Coty Says It Will Add First Woman Board Member by July